Chart 1From: Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney diseaseUnderlying Multi-compound, multi-target, multi-pathway network of Bupi Yishen formula in retarding progression of chronic kidney diseaseBack to article page